What’s New at Capitainer – Product launch, automation and SKUP results

October flew by –
We officially launched Capitainer®DIP70, expanding self-sampling beyond blood and plasma, while the SKUP evaluation demonstrated good repeatability and user-friendliness.

Here are some highlights from October 🎃

Capitainer®DIP70 – urine sampling

We’re proud to officially launch Capitainer®DIP70 – our urine sampling device.
DIP70 collects and stores two defined volumes in a dried format, making shipment and storage simple and stable.

Together with Capitainer®B-series for blood and Capitainer®SEP10 for plasma, we now offer a complete solution for decentralized sampling.

miQro Mingle

🤝 A mingle to remember – miQro hosted partners and friends in Providence

Earlier this month, our U.S. laboratory miQro Lab Solutions opened its doors for a miQro Mingle.
Partners, collaborators and friends joined us for a relaxed evening with lab tours, snacks, and great conversations about the future of microsampling.

It was a wonderful opportunity to connect, exchange ideas, and celebrate ongoing collaborations!

Automation joins the miQro team

As we hinted earlier on LinkedIn, we had a special happening during our miQro Mingle – our friends from BSD Robotics stopped by to deliver their Pre-Analytical Card Handler.

The system is now being evaluated at miQro Lab Solutions, our U.S. laboratory in Rhode Island, where it will support further automation of dried microsample processing – from card handling to analysis preparation. It also marks an important step toward future automation solutions compatible with Capitainer® devices.

Later that week, they assisted with the installation and provided excellent on-site training.

Take a look!

📊 SKUP evaluation confirms performance of Capitainer®B10

A recent evaluation by SKUP (Scandinavian Evaluation of Laboratory Equipment for Point-of-Care Testing) assessed the analytical performance of Capitainer®B10 for blood sampling and use for HbA1c testing on Roche cobas®.
In the evaluation over 300 patients sampled with Capitainer and the study demonstrated good repeatability and user-friendliness and passed the strict criterias of the evaluation.
A small bias, known from before for this analyte in dried samples, is seen and we comment in the report how this easily can be handled and corrected in the clinical laboratory.

These findings support the use of Capitainer®B10 for reliable and standardized microsampling of this important biomarker for monitoring and diagnosing diabetes.

👉 Read the full report here.

Stay Connected

Happy Halloween 🎃👻